A better understanding of crosstalk between Notch signaling and other pathways, such as Wnt, Hedgehog, and vascular endothelial growth factor (VEGF), as well as with the immune system can provide valuable clues how to target cancer survival by ablating them and will make JAG1, an attractive approach orchestrated for combination therapy. Here, JAG1 is linked to cancer.